These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

343 related articles for article (PubMed ID: 24602463)

  • 21. A pilot study to determine the dose and effectiveness of adrenocorticotrophic hormone (H.P. Acthar® Gel) in nephrotic syndrome due to idiopathic membranous nephropathy.
    Hladunewich MA; Cattran D; Beck LH; Odutayo A; Sethi S; Ayalon R; Leung N; Reich H; Fervenza FC
    Nephrol Dial Transplant; 2014 Aug; 29(8):1570-7. PubMed ID: 24714414
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Negative Modulation of B Cell Activation by Melanocortin 1 Receptor Signaling Protects against Membranous Nephropathy.
    Chen B; Guan X; Gunning WT; Ge Y; Gohara AF; Dworkin LD; Gong R
    J Am Soc Nephrol; 2023 Mar; 34(3):467-481. PubMed ID: 36446431
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Minimal change nephropathy and focal segmental glomerulosclerosis.
    Mathieson PW
    Semin Immunopathol; 2007 Nov; 29(4):415-26. PubMed ID: 17955243
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Histological classification of chronic glomerular diseases].
    Noël LH; Gubler MC
    Rev Prat; 2003 Nov; 53(18):2005-12. PubMed ID: 15008214
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effects of melanocortin 1 receptor agonists in experimental nephropathies.
    Lindskog Jonsson A; Granqvist A; Elvin J; Johansson ME; Haraldsson B; Nyström J
    PLoS One; 2014; 9(1):e87816. PubMed ID: 24498203
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Relapse of Nephrotic Syndrome after Adrenocorticotropic Hormone-Induced Remission: Implications of Adrenocorticotropic Hormone Antibodies.
    Shrivastava S; Chen B; Dworkin LD; Malhotra DK; Gong R
    Am J Nephrol; 2020; 51(5):390-394. PubMed ID: 32187600
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The spectrum of glomerular diseases as studied by immunofluorescence microscopy a single center study in Iraq.
    Al-Saegh RM; Assad LW
    Arab J Nephrol Transplant; 2013 Sep; 6(3):161-7. PubMed ID: 24053742
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pdlim2 is a novel actin-regulating protein of podocyte foot processes.
    Sistani L; Dunér F; Udumala S; Hultenby K; Uhlen M; Betsholtz C; Tryggvason K; Wernerson A; Patrakka J
    Kidney Int; 2011 Nov; 80(10):1045-54. PubMed ID: 21814175
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Drug-induced glomerular diseases.
    Garnier AS; Laubacher H; Briet M
    Therapie; 2024; 79(2):271-281. PubMed ID: 37973491
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Relapse of nephrotic syndrome following remission for 20 years.
    Cuoghi D; Vangelista A; Baraldi A; Cheli E
    Int J Pediatr Nephrol; 1983 Sep; 4(3):211-4. PubMed ID: 6315615
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Reduced INF2 expression in nephrotic syndrome is possibly related to clinical severity of steroid resistance in children.
    Tamura H; Nakazato H; Kuraoka S; Yoneda K; Takahashi W; Endo F
    Nephrology (Carlton); 2016 Jun; 21(6):467-75. PubMed ID: 26383224
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Incidence of remission and relapse of proteinuria, end-stage kidney disease, mortality, and major outcomes in primary nephrotic syndrome: the Japan Nephrotic Syndrome Cohort Study (JNSCS).
    Yamamoto R; Imai E; Maruyama S; Yokoyama H; Sugiyama H; Nitta K; Tsukamoto T; Uchida S; Takeda A; Sato T; Wada T; Hayashi H; Akai Y; Fukunaga M; Tsuruya K; Masutani K; Konta T; Shoji T; Hiramatsu T; Goto S; Tamai H; Nishio S; Shirasaki A; Nagai K; Yamagata K; Hasegawa H; Yasuda H; Ichida S; Naruse T; Nishino T; Sobajima H; Tanaka S; Akahori T; Ito T; Terada Y; Katafuchi R; Fujimoto S; Okada H; Ishimura E; Kazama JJ; Hiromura K; Mimura T; Suzuki S; Saka Y; Sofue T; Suzuki Y; Shibagaki Y; Kitagawa K; Morozumi K; Fujita Y; Mizutani M; Shigematsu T; Kashihara N; Sato H; Matsuo S; Narita I; Isaka Y
    Clin Exp Nephrol; 2020 Jun; 24(6):526-540. PubMed ID: 32146646
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Glomerular Glucocorticoid Receptors Expression and Clinicopathological Types of Childhood Nephrotic Syndrome.
    Gamal Y; Badawy A; Swelam S; Tawfeek MS; Gad EF
    Fetal Pediatr Pathol; 2017 Feb; 36(1):16-26. PubMed ID: 27690709
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Mechanisms and consequences of TGF-ß overexpression by podocytes in progressive podocyte disease.
    Lee HS
    Cell Tissue Res; 2012 Jan; 347(1):129-40. PubMed ID: 21541658
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Effect of cyclosporin A on renal function in patients with glomerulonephritis].
    Heering P; Schneider A; Grabensee B; Plum J
    Dtsch Med Wochenschr; 2001 Oct; 126(40):1093-8. PubMed ID: 11588659
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Soluble CD40 ligand directly alters glomerular permeability and may act as a circulating permeability factor in FSGS.
    Doublier S; Zennaro C; Musante L; Spatola T; Candiano G; Bruschi M; Besso L; Cedrino M; Carraro M; Ghiggeri GM; Camussi G; Lupia E
    PLoS One; 2017; 12(11):e0188045. PubMed ID: 29155846
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Transient receptor potential channel 6 (TRPC6) protects podocytes during complement-mediated glomerular disease.
    Kistler AD; Singh G; Altintas MM; Yu H; Fernandez IC; Gu C; Wilson C; Srivastava SK; Dietrich A; Walz K; Kerjaschki D; Ruiz P; Dryer S; Sever S; Dinda AK; Faul C; Reiser J
    J Biol Chem; 2013 Dec; 288(51):36598-609. PubMed ID: 24194522
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Repository corticotropin injection versus corticosteroids for protection against renal damage in a focal segmental glomerulosclerosis rodent model.
    Hayes K; Warner E; Bollinger C; Wright D; Fitch RM
    BMC Nephrol; 2020 Jun; 21(1):226. PubMed ID: 32539845
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Glomerular endothelial cell injury and focal segmental glomerulosclerosis lesion in idiopathic membranous nephropathy.
    Morita M; Mii A; Shimizu A; Yasuda F; Shoji J; Masuda Y; Ohashi R; Nagahama K; Kaneko T; Tsuruoka S
    PLoS One; 2015; 10(4):e0116700. PubMed ID: 25875837
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Glomerular anionic sites in minimal change nephrotic syndrome and focal segmental glomerulosclerosis.
    Kitano Y; Yoshikawa N; Nakamura H
    Clin Nephrol; 1993 Oct; 40(4):199-204. PubMed ID: 8261675
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.